We next investigated Nox5 protein levels in benign prostate and PCa tissue via immunohistochemical staining of a TMA comprising 3 tumor and 1 benign tissue cores each for 48 patients using a highly specific Nox5 antibody (Figure 2 and Supplemental Figure S1). The gene discussed is NOX5; the disease is posterior cortical atrophy.